Skip to main content
SpringerLink
Log in

Technology for Drug Safety: Challenges

  • Chapter
  • First Online:
Technology for Drug Safety

Part of the book series: Health Informatics ((HI))

Abstract

This chapter aims to discuss the challenges associated with the use of technology in various aspects of drug safety issues, including drug development, pharmacovigilance, adverse drug reactions and medication error reporting, drug-related problems, drug abuse and misuse, counterfeit medications, and antimicrobial stewardship. While technology has the potential to improve patient outcomes and reduce healthcare costs, there are several challenges that need to be addressed, including limited adoption of technology, limited resources, complexity of data integration, limited expertise, limited interoperability, privacy concerns, limited scalability, complexity of antimicrobial resistance, resistance to change, limited evidence of effectiveness, limited data availability, integration with clinical workflows, limited education and training, limited patient engagement, limited standardization, legal and regulatory barriers, limited access to technology, and limited collaboration between stakeholders. Addressing these challenges requires collaboration between various stakeholders, including healthcare providers, pharmaceutical companies, regulatory agencies, and technology companies. Furthermore, there is a need for continued innovation and investment in technology solutions that can address the challenges of drug-related problems, drug abuse and misuse, counterfeit medications, and antimicrobial stewardship. Ultimately, the use of technology must be integrated into existing clinical workflows and must be user-friendly and accessible to all healthcare providers and patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Al-Worafi YM, editor. Drug safety in developing countries: achievements and challenges; 2020.

    Google Scholar 

  2. Al-Worafi YM. Technology in medications safety. In: Drug safety in developing countries. Academic Press; 2020. p. 203–12.

    Chapter  Google Scholar 

  3. Al-Worafi YM. Medications safety-related terminology. In: Drug safety in developing countries. Academic Press; 2020. p. 7–19.

    Chapter  Google Scholar 

  4. Al-Worafi YM. Medications registration and marketing: safety-related issues. In: Drug safety in developing countries. Academic Press; 2020. p. 21–8.

    Chapter  Google Scholar 

  5. Al-Worafi YM. Pharmacovigilance. In: Drug safety in developing countries. Academic Press; 2020. p. 29–38.

    Chapter  Google Scholar 

  6. Al-Worafi YM. Adverse drug reactions. In: Drug safety in developing countries. Academic Press; 2020. p. 39–57.

    Chapter  Google Scholar 

  7. Al-Worafi YM. Medication errors. In: Drug safety in developing countries. Academic Press; 2020. p. 105–17.

    Chapter  Google Scholar 

  8. Al-Worafi YM. Drug-related problems. In: Drug safety in developing countries. Academic Press; 2020. p. 59–71.

    Chapter  Google Scholar 

  9. Al-Worafi YM. Self-medication. In: Drug safety in developing countries. Academic Press; 2020. p. 73–86.

    Chapter  Google Scholar 

  10. Al-Worafi YM. Antibiotics safety issues. In: Drug safety in developing countries. Academic Press; 2020. p. 87–103.

    Chapter  Google Scholar 

  11. Al-Worafi YM. Medications safety research issues. In: Drug safety in developing countries. Academic Press; 2020. p. 213–27.

    Chapter  Google Scholar 

  12. Al-Worafi YM. Counterfeit and substandard medications. In: Drug safety in developing countries. Academic Press; 2020. p. 119–26.

    Chapter  Google Scholar 

  13. Al-Worafi YM. Medication abuse and misuse. In: Drug safety in developing countries. Academic Press; 2020. p. 127–35.

    Chapter  Google Scholar 

  14. Al-Worafi YM. Storage and disposal of medications. In: Drug safety in developing countries. Academic Press; 2020. p. 137–42.

    Chapter  Google Scholar 

  15. Al-Worafi YM. Herbal medicines safety issues. In: Drug safety in developing countries. Academic Press; 2020. p. 163–78.

    Chapter  Google Scholar 

  16. Al-Worafi YM. Evidence-based medications safety practice. In: Drug safety in developing countries. Academic Press; 2020. p. 197–201.

    Chapter  Google Scholar 

  17. Al-Worafi YM. Quality indicators for medications safety. In: Drug safety in developing countries. Academic Press; 2020. p. 229–42.

    Chapter  Google Scholar 

  18. Al-Worafi YM. Drug safety: comparison between developing countries. In: Drug safety in developing countries. Academic Press; 2020. p. 603–11.

    Chapter  Google Scholar 

  19. Al-Worafi YM. Drug safety in developing versus developed countries. In: Drug safety in developing countries. Academic Press; 2020. p. 613–5.

    Chapter  Google Scholar 

  20. Battles JB, Keyes MA. Technology and patient safety: a two-edged sword. Biomed Instrum Technol. 2002;36(2):84–8.

    Google Scholar 

  21. Huckvale C, Car J, Akiyama M, Jaafar S, Khoja T, Khalid AB, et al. Information technology for patient safety. BMJ Qual Saf. 2010;19(Suppl 2):i25–33.

    Article  Google Scholar 

  22. Lu Z. Information technology in pharmacovigilance: benefits, challenges, and future directions from industry perspectives. Drug Healthc Patient Saf. 2009:35–45.

    Google Scholar 

  23. Al-Worafi Y. A guide to online pharmacy education: teaching strategies and assessment methods. CRC Press; 2022.

    Book  Google Scholar 

  24. Al-Worafi YM, editor. Clinical case studies on medication safety. Academic Press; 2023.

    Google Scholar 

  25. Elangovan D, Long CS, Bakrin FS, Tan CS, Goh KW, Hussain Z, et al. Application of blockchain technology in hospital information system. In: Mathematical modeling and soft computing in epidemiology; 2020. p. 231–46.

    Chapter  Google Scholar 

  26. Izahar S, Lean QY, Hameed MA, Murugiah MK, Patel RP, Al-Worafi YM, et al. Content analysis of mobile health applications on diabetes mellitus. Front Endocrinol. 2017;8:318.

    Article  Google Scholar 

  27. Loy MJ, Goh KW, Osili N, Ming LC, Dhaliwal JS, Hermansyah A, et al. Features and functionalities of medical mobile applications for the endemic phase of COVID-19: review and content analysis. Prog Microbes Mol Biol. 2022;5(1).

    Google Scholar 

  28. Kumaran H, Long CS, Bakrin FS, Tan CS, Goh KW, Al-Worafi YM, et al. Online pharmacies: desirable characteristics and regulations. Drugs Ther Perspect. 2020;36:243–5.

    Article  Google Scholar 

  29. Ming LC, Hameed MA, Lee DD, Apidi NA, Lai PSM, Hadi MA, et al. Use of medical mobile applications among hospital pharmacists in Malaysia. Ther Innov Regul Sci. 2016;50(4):419–26.

    Article  Google Scholar 

  30. Ming LC, Untong N, Aliudin NA, Osili N, Kifli N, Tan CS, et al. Mobile health apps on COVID-19 launched in the early days of the pandemic: content analysis and review. JMIR Mhealth Uhealth. 2020;8(9):e19796.

    Article  Google Scholar 

  31. Ng CZ, Lean YL, Yeoh SF, Lean QY, Lee KS, Suleiman AK, et al. Cold chain time-and temperature-controlled transport of vaccines: a simulated experimental study. Clin Exp Vaccine Res. 2020;9(1):8–14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of Science and Technology of Fujairah, Fujairah, UAE

    Yaser Mohammed Al-Worafi

  2. College of Medical Sciences, Azal University for Human Development, Sana’a, Yemen

    Yaser Mohammed Al-Worafi

Authors
  1. Yaser Mohammed Al-Worafi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Al-Worafi, Y.M. (2023). Technology for Drug Safety: Challenges. In: Technology for Drug Safety. Health Informatics. Springer, Cham. https://doi.org/10.1007/978-3-031-34268-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-34268-4_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-34267-7

  • Online ISBN: 978-3-031-34268-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation